Ramsey Hachem is a Respiratory physician. ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4921 Parkview Pl
Div Im Pulmonary And Ccm, 8th Fl
Saint Louis, MO 631101032
Telephone
314-454-8917Provider last certified this registry record 8 Dec 2024.
Clinical trials
- A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection After Lung Transplantation
Sponsor: Washington University School of Medicine
- Tocilizumab in Lung Transplantation
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
- Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation
Sponsor: Washington University School of Medicine
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- TransMedics, Inc.Program year20252 payments
- Aimmune Therapeutics, Inc.Program year20251 payment
- TransMedics, Inc.Program year20243 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
29.2%Short-acting sulfonamides14.4%Sulfamethoxazole-Trimethoprim100%Part D≥123 patientsMacrolide Antimicrobial10.5%Azithromycin100%Part D≥94 patients+ 5 more classes in this area
Metabolism & gastrointestinal
23.5%Corticosteroid11.7%Prednisone100%Part D≥95 patientsProton pump inhibitor9.2%Pantoprazole Sodium75%Omeprazole20%Esomeprazole Magnesium5%Part D<11 patients+ 4 more classes in this area
Dermatology
15.1%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor15.1%Acyclovir100%Part D≥129 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2010–2023 per NIH RePORTER. The latest:
- A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection after Lung Transplantation
Washington University
FY2023$371,405R61HL169189 - A Pilot Randomized Controlled Trial of De Novo Belatacept-Based Immunosuppression in Lung Transplantation
Washington University
FY2020$237,979R34HL138186 - A Pilot Randomized Controlled Trial of De Novo Belatacept-Based Immunosuppression in Lung Transplantation
Washington University
FY2019$237,524R34HL138186
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”